Keratinocytic Vascular Endothelial Growth Factor as a Novel Biomarker for Pathological Skin Condition
Biomolecules & Therapeutics
;
: 12-18, 2015.
Article
in English
| WPRIM
| ID: wpr-20366
ABSTRACT
Skin is an emerging target tissue in pharmaceutical and cosmetic science. Safety assessment for dermal toxicity is a critical step for development of topically applicable pharmaceutical agents and ingredients in cosmetics. Urgent needs exist to set up toxicity testing methods for dermal safety, and identification of novel biomarkers for pathological cutaneous alteration is highly required. Here we will discuss if vascular endothelial growth factor (VEGF) has a potential as a biomarker for dermal impairment. Experimental and clinical evidences for induction of keratinocytic VEGF under pathological conditions will be reviewed.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Skin
/
Biomarkers
/
Toxicity Tests
/
Vascular Endothelial Growth Factor A
Type of study:
Prognostic study
Language:
English
Journal:
Biomolecules & Therapeutics
Year:
2015
Type:
Article
Similar
MEDLINE
...
LILACS
LIS